Destiny Pharma (DEST) RNS Announcements

Add to Alert list
Date Time Source Announcement
23 Aug 2021 07:00 AM
RNS
Notice of Interim Results
02 Aug 2021 07:00 AM
RNS
Secondary endpoint analysis from Phase 2b trial
09 Jul 2021 08:00 AM
RNS
XF-73 Phase 2b data to be presented at ECCMID
06 Jul 2021 07:00 AM
RNS
NTCD-M3 RD Agreement with US Dept Veterans Affairs
02 Jul 2021 08:00 AM
RNS
Scientific Advisor Gerding chairs C Diff symposium
29 Jun 2021 08:24 AM
RNS
DEST to present at Shares & AJ Bell Webinar 6/7/21
10 Jun 2021 05:00 PM
RNS
Director Dealing
10 Jun 2021 07:00 AM
RNS
XF-73 data abstract to be presented at 2021 ECCMID
07 Jun 2021 07:00 AM
RNS
Destiny Pharma welcomes G7's Communique on AMR
03 Jun 2021 12:03 PM
RNS
Result of AGM
02 Jun 2021 07:00 AM
RNS
Positive update on microbiome therapeutic NTCD-M3
25 May 2021 07:00 AM
RNS
Further information re AGM
19 May 2021 07:00 AM
RNS
Notice to Register for 2021 AGM
06 May 2021 10:00 AM
RNS
Conference Attendance for May 2021
04 May 2021 07:00 AM
RNS
Posting of Annual Report and Notice of AGM
30 Apr 2021 07:00 AM
RNS
Director Dealing
23 Apr 2021 07:00 AM
RNS
Director Dealing
15 Apr 2021 08:00 AM
RNS
FY 2020 Investor Presentation
14 Apr 2021 07:00 AM
RNS
Final Results
29 Mar 2021 12:45 PM
RNS
Exercise of Options and Total Voting Rights
29 Mar 2021 12:00 PM
RNS
Destiny Pharma to Join Equity Development Webinar
29 Mar 2021 11:06 AM
RNS
Second Price Monitoring Extn
29 Mar 2021 11:00 AM
RNS
Price Monitoring Extension
29 Mar 2021 10:15 AM
RNS
Exercise of Options and Total Voting Rights
29 Mar 2021 09:06 AM
RNS
Second Price Monitoring Extn
29 Mar 2021 09:00 AM
RNS
Price Monitoring Extension
29 Mar 2021 07:00 AM
RNS
Destiny Pharma Reports Positive Phase 2b Results
16 Mar 2021 07:00 AM
RNS
Notice of Results
15 Mar 2021 07:00 AM
RNS
Destiny Pharma Announces Agreement with NIAID
10 Mar 2021 02:15 PM
RNS
Exercise of Options and Total Voting Rights
10 Mar 2021 07:00 AM
RNS
Destiny Pharma CSO Joins UKRI COVID-19 Taskforce
10 Feb 2021 02:05 PM
RNS
Second Price Monitoring Extn
10 Feb 2021 02:00 PM
RNS
Price Monitoring Extension
03 Feb 2021 07:00 AM
RNS
Brazilian Patent Granted for XF-73 nasal gel
02 Feb 2021 07:05 AM
RNS
Destiny Pharma to join panel discussion at LSX
02 Feb 2021 07:00 AM
RNS
Destiny Pharma Appoints Professor Mark Wilcox
21 Jan 2021 04:41 PM
RNS
Second Price Monitoring Extn
21 Jan 2021 04:35 PM
RNS
Price Monitoring Extension
21 Jan 2021 04:31 PM
RNS
Grant of Share Options
21 Jan 2021 08:28 AM
RNS
Destiny Pharma Investor Presentation
14 Jan 2021 11:05 AM
RNS
Second Price Monitoring Extn
14 Jan 2021 11:00 AM
RNS
Price Monitoring Extension
07 Jan 2021 11:05 AM
RNS
Second Price Monitoring Extn
07 Jan 2021 11:00 AM
RNS
Price Monitoring Extension
07 Jan 2021 07:00 AM
RNS
Destiny Pharma: Directors Dealings
06 Jan 2021 08:00 AM
RNS
Destiny Pharma Appoints Stephanie Bewick as CBO
05 Jan 2021 07:00 AM
RNS
Phase 2b trial of XF-73 completes recruitment
23 Dec 2020 02:09 PM
RNS
Grant of share options
22 Dec 2020 07:00 AM
RNS
Update on the recently acquired NTCD-M3 programme
01 Dec 2020 05:23 PM
RNS
Holding(s) in Company
UK 100

Latest directors dealings